A Medical Information request about a potential safety signal, the preparation of a clinical dossier, or the review of a scientific claim cannot rely on a simple keyword search. Literature searching in scientific databases is a documented process that transforms an operational question into selected, verifiable evidence that can be applied in the appropriate context.
For pharmaceutical, biotech, and medtech companies, the quality of a literature search depends on more than the number of publications retrieved. Relevance to the product and patient population, methodological quality of the sources, time coverage, and reproducibility of the search strategy are equally important. A well-designed search therefore strengthens both scientific and regulatory decision-making.
When literature searching becomes a critical activity
Not every information need requires the same level of depth. An exploratory search may help guide an internal assessment or map a therapeutic area. A systematic search, on the other hand, requires predefined inclusion and exclusion criteria, a formalized search strategy, and a traceable selection process.
Examples of activities that fall between these two approaches include:
- literature updates for Medical Information;
- monitoring new evidence on efficacy and safety;
- supporting the preparation of clinical documents;
- post-market evaluations for medical devices;
- identifying case reports and compliance-relevant information.
Literature searching in scientific databases: from question to strategy
The starting point is a clearly defined question. Generic expressions such as “product safety” or “efficacy in elderly patients” are not sufficient. It is necessary to define the population, intervention or exposure, comparator when relevant, outcome, time period, and study types of interest.
For clinical questions, the PICO framework (Population, Intervention, Comparison, Outcome) helps clarify the essential elements of the search. In pharmacovigilance, greater emphasis is often placed on the active substance, adverse event, alternative product names, drug interactions, and case characteristics. For medical devices, searches may include technology, intended use, healthcare setting, and post-market surveillance data.
Once the scope has been defined, the search strategy is built using a combination of controlled vocabulary terms and free-text keywords. Controlled vocabularies improve consistency when retrieving indexed articles, while free-text terms help identify recent publications, acronyms, terminology variants, and brand names.
Boolean operators, truncation symbols, and filters must also be used carefully. A search strategy that is too restrictive may exclude important evidence, whereas an overly broad search may generate an unmanageable number of results. Sensitivity and specificity should be balanced according to the research question and the level of associated risk.
Choosing the right sources
Scientific databases differ in coverage, historical depth, and indexing methods. PubMed/MEDLINE is a key resource for biomedical literature, but it does not contain all available evidence. Embase offers valuable coverage of pharmaceuticals, conference proceedings, and international publications. The Cochrane Library is particularly relevant for systematic reviews and controlled studies, while Scopus and Web of Science support citation tracking and broader literature exploration.
Depending on the objective, additional sources may include clinical trial registries, regulatory resources, conference proceedings, grey literature, and specialized databases.
Using more databases is not automatically better. Sources should be selected and justified based on their ability to answer the research question while limiting unnecessary duplication and dispersion. Access to a database alone does not guarantee quality. Effective literature searching requires an understanding of each database’s structure, limitations, and search functionality.
Screening, critical appraisal, and traceability
A list of retrieved records does not yet constitute a scientific output. Results should be deduplicated and undergo a progressive screening process, first through titles and abstracts and then through full-text review of potentially relevant publications.
Relevance is not always synonymous with quality. A study may address the research question while presenting limitations related to study design, sample size, follow-up duration, or applicability to the target population. Conversely, a high-quality review may be methodologically robust but fail to include the most recent evidence.
Critical appraisal should therefore distinguish between:
- level of evidence;
- reliability of the data;
- relevance to the research question;
- importance for decision-making.
This distinction helps avoid overinterpretation and enables an accurate representation of conflicting findings, uncertainties, and evidence gaps.
Traceability should include the original question, databases searched, search dates, search strings, filters applied, selection criteria, and included references. Such documentation facilitates audits, updates, and cross-functional review among Medical Affairs, Pharmacovigilance, Regulatory Affairs, and Quality Assurance teams.
Common mistakes that reduce reliability
One common mistake is relying on a single database to answer complex questions. While this may be acceptable for narrowly focused topics, it becomes more problematic when safety, technology comparisons, or regulatory evaluations are involved.
Another limitation is using only natural-language keywords while ignoring synonyms, historical terminology, and controlled vocabulary terms. Automated application of date or language filters may also reduce coverage and prevent the identification of relevant evidence.
In addition, the search process should not end with a simple bibliography file. End users require a structured synthesis that highlights the main findings, limitations, relevance, and supporting sources. The format should be tailored to its purpose: a Medical Information response, a safety assessment, and a clinical evaluation report require different levels of depth and analysis.
Integrating literature searches into life sciences processes
Literature searching is most effective when it is integrated into the processes that depend on it. Periodic monitoring can support updates to standard Medical Information responses. Searches focused on adverse events can contribute to signal evaluation. Selected evidence can also support medical writing activities, training materials, and clinical documents.
This integration reduces informal information flows and minimizes the risk of inconsistent messages arising from different sources. However, it requires clearly defined roles, version control, approval processes, and a clear distinction between published data, scientific interpretation, and communication that is permissible within the applicable regulatory framework.
Eureka InfoMed approaches literature searching as part of an integrated specialist service. Scientific literature is not treated as a stand-alone deliverable but as a documentary foundation that supports medical, safety, regulatory, and scientific communication activities.
When literature is managed using a structured methodology, every decision starts with a more precise question and leaves behind a verifiable record. This is the operational value of literature searching in scientific databases: making evidence accessible, defensible, and genuinely useful when it is needed most.
Sources
- National Library of Medicine (NLM). PubMed User Guide.
- Cochrane Handbook for Systematic Reviews of Interventions. Search Methods and Information Sources.
- PRISMA 2020 Statement. Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.